Indonesia Scraps Year-End Covid Curbs as Vaccination Rate Improves
(Bloomberg) -- Indonesia canceled its planned restrictions for the year-end period as its Covid-19 vaccination coverage and testing capacity have improved.
The government won't impose the second-highest level of restrictions, or level 3, across the country and will instead order varied curbs depending on the local situation, Coordinating Minister for Maritime and Investment Affairs Luhut Panjaitan, who's overseeing the pandemic response, said in a statement. Travel is limited to those who are fully vaccinated.
Indonesia had ordered the restrictions as previous holiday seasons have led to spikes in Covid-19 cases. It had previously told governors to stop all workers, including private-sector employees, from taking leave from Dec. 24 through Jan. 2 and urged schools to cancel their year-end break.Â
The country's vaccination coverage remains relatively low, with about 53% of people receiving at least the first dose and 37% fully inoculated. Case numbers are hovering near the lowest in more than a year with fewer than 10 fatalities in the last four days. The government has ramped up testing to keep the positivity rate, the proportion of those tested who turn out to have been infected with the coronavirus, at 0.2%. That's much lower than the World Health Organization recommendation for the rate to be below 5%.
©2021 Bloomberg L.P.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.